Endocrine Research Updates

For Medical Professionals

Acromegaly requires early and effective treatment to restore quality of life;
When surgery is not pursued as first-line therapy, medication selection is critical to address risk of diabetes, hypertension, and cardiovascular disease to assure best long-term management.
Monitoring patients for signs hypparaothryoidism following thyroid surgery.
American Thyroid Association Statement offers recommendations for clinical management of hypoparathyroidism following thyroid surgery.
FDA grants orphan drug status to thyroid cancer and hypoparathyroidism.
Next generation tubeless Omnipod DASH Insulin Management System coming to market, a novel nasal spray product for diabetes gastoparesis is under review., and orphan drug status granted for treatment of hypoparathyroidism and anaplastic thyroid cancer..
Cushing's syndrome and Cushing's disease requires multimodal care.
Results of two systematic reviews indicate that while surgery is the preferred treatment, many patients present with contraindications without an accepted management paradigm leaving clinicians to follow a patient-centric approach to care.
Several novel diabetes management devices and technolgoy advances are approaching FDA review including first of its kind all-in-one patch, a much anticipated insulin capsule, and a shelf-stable glucagon rescue pen for severe hypoglycemia.
Transgender hormone therapy increases the risks of heart attack and stroke.
As more individuals seek transgender hormone therapy, clinicians will want to be prepared to monitor for increased risks of cardiovascular events.
Symptoms of Hashimoto's disease are worsened in women with PCOS.
Hashimoto's disease (autoimmune thyroiditis) worsens reproductive and metabolic outcomes in patients with polycystic ovary syndrome.
wearable devices, glucose devices, diabetes technology
Brief highlights on prescription medication rating tool, reimbursement for use of wearable health tracking devices and an assessment of the health technology field.
Hormone replacement for low testosterone requires a proper diagnosis.
Addressing an age-related decline in serum testosterone is not clinically advisable whereas hypogonadism requires appropriately diagnosed medical intervention.
Risk of autoimmune diseases, such as diabetes, increased by Epstein-Barr virus.
Researchers uncover genetic link involving b cells that suggest an increased risk of developing at least seven identified autoimmune disorders, including type 1 diabetes, following a person's infection with the Epstein-Barr virus.
Researchers find underlying cause of treatment failure for standard BP care.
Researchers uncovered excess aldosterone as cause of antihypertensive treatment failure, and shed light on mechanisms to support breakthrough treatment success in resistant hypertension.
Women with PCOS may have hypothryoidism which have implications for pregnancy.
Women with polycystic ovary syndrome appear at increased risk for comorbid thyroid disorders, yet a study by researchers from the Cleveland Clinic introduced more questions about pregnancy outcomes.
Diabetes care is now achieving Integrated Continuous Glucose Monitoring.
A round-up of recent diabetes products and updated innovations and indications considered by the Food and Drug Administration, highlighting the first integrated CGM and first implantable glucose sensor.
Seeking new biomarker to identify greater diabetes risk for heart disease.
Evaluating a possible role for FGF-23 in CHD, accounting for differences in race, sex, and chronic kidney disease status from a subset of the REGARDS data
Innovations in diabetes care explode with 3 new diabetes products introduced.
March brings 3 diabetes product innovations, a clinician office task organizer app, and a warning about patient perceptions regarding attatins: they don't need them.
Patients will benefit from less intensive treatment to reduce hemoglobin A1c.
Need for intensive drug treatment to reduce hemoglobin A1C targets called into question by the American College of Physicians but defended by the leading endocrine-related organizations, placing clinicians in the middle of debate over T2D treatment.
In-office device enables earlier screening for common eye disease in diabetes.
The ability to assess eye health in patients with diabetes can begin with an in-office screening using artificial intelligence software, accelerating referral to an ophthalmologist for earlier treatment.
Survival is not affected by thyroid tumors of less than 2.5 cm.
Duke University research team reported no need to biopsy thyroid nodules measuring less than 2.5 cm since there is no apparent effect on survival.
Lipid guidelines can inform treatment, but should be individualized.
Given so many guidelines for hyperlipidemia, the best approach is individualizing care, informed by evidence-based treatment recommendations.
close X